Technical Analysis for NTRA - Natera, Inc.

Grade Last Price % Change Price Change
grade F 14.6 0.27% 0.04
NTRA closed up 0.27 percent on Friday, January 18, 2019, on 1.45 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical NTRA trend table...

Date Alert Name Type % Chg
Jan 18 Stochastic Sell Signal Bearish 0.00%
Jan 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Doji - Bearish? Reversal 0.00%
Jan 18 Weak + Overbought Other 0.00%
Jan 18 Weak, Overbought and Reversal Signs Reversal 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 18 Up 5 Days in a Row Strength 0.00%

Older signals for NTRA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Natera, Inc., a genetic testing company, develops and commercializes non-invasive methods for analyzing deoxyribonucleic acid (DNA) in the United States and Europe. The company primarily offers Panorama, a non-invasive prenatal test for fetal chromosomal abnormalities; Horizon test; and pre-implantation genetic screening and pre-implantation genetic diagnosis tests under the Spectrum brand to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization. It also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal DNA in a pregnant mother's blood and a blood sample from the alleged father; and high throughput carrier screening to determine the risk of passing severe genetic diseases on to offspring. Natera sells its tests directly and partner with other clinical laboratories to distribute its tests. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.
Is NTRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.62
52 Week Low 8.6
Average Volume 700,410
200-Day Moving Average 17.9748
50-Day Moving Average 15.222
20-Day Moving Average 13.0785
10-Day Moving Average 13.255
Average True Range 1.0729
ADX 24.75
+DI 25.2259
-DI 21.0481
Chandelier Exit (Long, 3 ATRs ) 11.9613
Chandelier Exit (Short, 3 ATRs ) 14.2987
Upper Bollinger Band 14.8664
Lower Bollinger Band 11.2906
Percent B (%b) 0.93
BandWidth 27.341056
MACD Line -0.3599
MACD Signal Line -0.7901
MACD Histogram 0.4302
Fundamentals Value
Market Cap 777.05 Million
Num Shares 53.2 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -6.01
Price-to-Sales 2.91
Price-to-Book 11.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.91
Resistance 3 (R3) 15.95 15.57 15.69
Resistance 2 (R2) 15.57 15.23 15.54 15.61
Resistance 1 (R1) 15.08 15.03 14.89 15.04 15.54
Pivot Point 14.70 14.70 14.60 14.67 14.70
Support 1 (S1) 14.21 14.36 14.02 14.17 13.66
Support 2 (S2) 13.83 14.16 13.80 13.59
Support 3 (S3) 13.34 13.83 13.51
Support 4 (S4) 13.30